MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: Oncology
Oncology

Optimizing Surgical Margins to Minimize Local Recurrence in Pediatric and Young Adult Nonrhabdomyosarcoma Soft Tissue Sarcoma: Insights from a Multicenter Trial

MedXY Editorial TeamNov 19, 2026
local recurrenceNonrhabdomyosarcoma soft tissue sarcomapediatric oncologySurgical margin

Highlight

  • The 5-year local recurrence rate after R0 resection in children and young adults with NRSTS was low (4.4%), supporting the effectiveness of risk-adapted multimodality therapy.

  • Wider negative surgical margins (≥6 mm) were associated with zero local recurrences, while margins of 1 mm carried a slightly higher recurrence risk (4.9%).

  • Close surgical margins may be adequate particularly when combined with chemoradiotherapy in selected patients, emphasizing a personalized risk-based approach.

  • Successful salvage therapies led to durable disease control in nearly half of patients experiencing local recurrence.

Study Background

Nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) represent a heterogeneous group of malignancies occurring in children and young adults, distinct from the more common rhabdomyosarcoma subtype. Surgical resection with negative margins remains the cornerstone of localized disease management. However, the optimal extent of pathological negative margins required to minimize local recurrence has been unclear. Excessively wide resections may contribute to functional morbidity, while narrow margins risk tumor persistence. This clinical equipoise underscores the need to define margin parameters that achieve durable local control without unnecessary morbidity, particularly in the pediatric and young adult populations where long-term function is critical. The Children’s Oncology Group (COG) ARST0332 trial investigated this question within a contemporary risk-adapted multimodality treatment framework.

Study Design

This prospective, multicenter, nonrandomized clinical trial enrolled 266 eligible patients younger than 30 years with nonmetastatic NRSTS between 2007 and 2012 at COG member sites, with a median follow-up of 6.2 years. Inclusion criteria mandated R0 resections (microscopically negative margins), excluding those undergoing amputation or non-protocol radiation. Surgical margins were centrally reviewed blinded to outcomes, and measured precisely in a subset (n=132). Patients received risk-adapted multimodality therapy grouped by tumor size, grade, margin extent, and initial resectability, involving upfront or delayed surgery, with or without radiation and/or ifosfamide/doxorubicin chemotherapy. The primary endpoints included cumulative incidence of local recurrence and local control outcomes based on surgical margins and treatment modalities.

Key Findings

Among 266 patients (median age 13.7 years; 52% female), 207 underwent upfront R0 surgery and 59 had delayed R0 surgery post-induction therapy. Measured surgical margins were categorized as 1 mm (56 patients), 2–5 mm (50 patients), or ≥6 mm (26 patients). Overall, the 5-year cumulative incidence of local recurrence was low at 4.4%.

By treatment modality, local recurrence occurred in 10 of 178 patients (5.6%) treated with surgery alone, versus 2 of 88 patients (2.3%) treated with surgery and chemoradiotherapy. Among patients with quantified margins, recurrence rates inversely correlated with margin width: 4.9% for 1 mm, 2.0% for 2–5 mm, and 0% for those with ≥6 mm clearances.

Tumor size and treatment intensity also influenced outcomes: local recurrence occurred in 5.6% of patients with tumors 5 cm receiving surgery plus chemoradiotherapy; and 1.7% in those with initially unresectable disease managed with neoadjuvant chemoradiotherapy. Notably, salvage treatment after recurrence yielded long-term disease control in 5 of 12 patients, emphasizing that local recurrence did not invariably herald poor prognosis.

Expert Commentary

This trial provides robust prospective evidence that precise pathological measurement of surgical margins can guide risk stratification for local recurrence in pediatric and young adult NRSTS. The data support less radical resections when planned within a risk-adapted protocol incorporating chemotherapy and radiation, thereby balancing oncologic control with preservation of function and quality of life. The finding that wider margins correlate with improved local control is consistent with oncologic principles but nuanced by the relatively low recurrence observed even with close margins, reinforcing the role of adjuvant therapies.

Limitations include the nonrandomized design and exclusion of patients undergoing amputation, which may limit generalizability to all NRSTS populations. Additionally, longer follow-up will further clarify late recurrences. From a biological standpoint, NRSTS comprises diverse histologies with distinct behaviors; thus, margin guidelines may require refinement based on subtype-specific patterns. Further molecular characterization may aid in individualized margin and treatment decisions.

Conclusion

This COG ARST0332 study establishes that in children and young adults with nonmetastatic NRSTS, R0 resection combined with risk-adapted multimodality therapy achieves low local recurrence rates. Wider negative margins greater than 1 mm further reduce recurrence risk, though close margins may be acceptable in the context of chemoradiotherapy. These findings reinforce the importance of personalized surgical planning and integrated oncologic care to optimize long-term outcomes while minimizing treatment-related morbidity. Future research should explore molecular predictors of local recurrence and refine margin recommendations by histologic subtype.

Funding and Trial Registration

This trial was funded and conducted under the auspices of the Children’s Oncology Group. The trial registration identifier is NCT00346164.

References

Hiniker SM, Dixon AH, Xue W, et al. Surgical Margin and Risk of Local Recurrence in Children and Young Adults With Nonrhabdomyosarcoma Soft Tissue Sarcoma: A Nonrandomized Clinical Trial. JAMA Surg. 2026 Oct 28. doi:10.1001/jamasurg.2026.42949735. PMID: 42949735.

Additional foundational references:
1. Ferrari A, Sultan I, Huang TT, et al. Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database. Pediatr Blood Cancer. 2011;57(6):943-949.
2. Stanelle EJ, Volden P, Beck JD, et al. Margin Status and Prognosis in Soft Tissue Sarcomas: A Meta-analysis. J Surg Oncol. 2019;119(2):215-224.

These and other studies contextualize surgical margin implications in NRSTS management.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Retinal Metastasis of Small-Cell Lung Cancer Masquerading as Cytomegalovirus Retinitis: A Case Report

OncologyNov 17, 2026

FDA Approves Roche’s Next-Generation Oral SERD Giredestrant for ESR1-Mutated Advanced Breast Cancer

OncologyNov 17, 2026

Pembrolizumab as a First-Line Therapy in dMMR Advanced or Recurrent Endometrial Cancer: Insights from the KEYNOTE-C93 Phase 3 Trial

OncologyNov 16, 2026
Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story